Skip to content

Unbilled balances at other companies

Labcorp Holdings logo
Labcorp HoldingsLH
Bruker logo
BrukerBRKR

Other financials

Income statement

See full
Revenue$619.8M-10.5%
Gross profit$263.8M-23.2%
Operating income-$31.8M-198%
Net income-$91.8M-623%
EPS (diluted)-$1.35-611%

Balance sheet

See full
Cash & equivalents$140.4M+10.4%
Total debt$3.1B+0.3%
Total equity$1.9B-38.2%
Total assets$5.6B-12.9%

Cash flow

See full
Operating cash flow-$33.0M-150%
CapEx$34.0M-39.5%
Free cash flow-$67.0M-813%

Valuation

See full
Market cap$921.94M-51.4%
Enterprise value$3.88B-20.1%
P/S0.4×-0.3×

Profitability

See full
Gross margin45%-2.0pp
Operating margin-37%-46.2pp
Net margin-45.6%-75.7pp
FCF margin13.8%

Returns & leverage

See full
Return on equity-49.9%-70.8pp
Debt / equity1.7×+0.6×
Current ratio1.4×+0.2×

Where this comes from

Reported directly by QuidelOrtho Corporation in its filing.

Tagged under the XBRL concept us-gaap:UnbilledContractsReceivable.

The official record: QuidelOrtho Corporation’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about QuidelOrtho Corporation's unbilled balances.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is QuidelOrtho Corporation's unbilled balances?
QuidelOrtho Corporation (QDEL) reported unbilled balances of $30.8M in Q1 2026.
How has QuidelOrtho Corporation's unbilled balances changed year-over-year?
QuidelOrtho Corporation's unbilled balances decreased by 6.4% year-over-year, from $32.9M to $30.8M.
What is the long-term trend for QuidelOrtho Corporation's unbilled balances?
Over 2 years (2023 to 2025), QuidelOrtho Corporation's unbilled balances has grown at a -13.3% compound annual growth rate (CAGR), from $46.2M to $34.7M.